Different levels of adherence to the Mediterranean diet that do not change the risk of breast cancer in western women

ABSTRACT Breast cancer (BC) is the most common neoplasm in women globally. Healthy eating, a characteristic of the Mediterranean diet (MD), has been associated with a lower risk of developing BC, although this relationship remains inconclusive. This study aimed to analyse the relationship between MD...

Descripción completa

Detalles Bibliográficos
Autores: Carvalho-Caldas,Daniele Rodrigues, Péres-Rodrigues,Gilmara, Lima-Cruz,Ellen Maria, Barbosa-Pereira,Patrícia, Costa da Silva,Paula Fernanda, Beserra de Moura,Mayara Storel, Borges de Araujo,Camila Guedes, Soares-Cavalcante,Regina Márcia, Nogueira,Nadir do Nascimento
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2022
País:Chile
Institución:Agencia Nacional de Investigación y Desarrollo
Repositorio:SciELO Chile
OAI Identifier:oai:scielo:S0717-75182022000700743
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-75182022000700743
Access Level:acceso abierto
Palabra clave:Breast cancer
Food consumption
Mediterranean diet
Descripción
Sumario:ABSTRACT Breast cancer (BC) is the most common neoplasm in women globally. Healthy eating, a characteristic of the Mediterranean diet (MD), has been associated with a lower risk of developing BC, although this relationship remains inconclusive. This study aimed to analyse the relationship between MD adherence and the risk of BC development. A case-control study was carried out with 181 women divided into two groups: with BC (n= 90) and without breast cancer (WBC) (n= 91). Clinical and reproductive aspects were investigated through interviews, and food consumption was assessed through a food frequency questionnaire (FFQ). Adherence to the MD was evaluated using the MD score. Statistical analysis was performed using SPSS® software, with p<0.05. The results showed that the main type of breast carcinoma was invasive ductal carcinoma, positive for oestrogen or progesterone receptors. The mean MD score was 4.08 ± 1.61 and 4.22 ± 1.69 among women with BC and without BC, respectively, with no difference between the groups. The risk assessment of BC with respect to adherence to MD showed no significant difference after adjustments were made in the logistic regression models. In conclusion, this study showed that women with and without breast cancer had &#8220;medium adherence&#8221; to MD, with no difference between the groups. In the group of women investigated, adherence to MD did not affect the risk of developing the disease.